Published: Jul 05, 2021
Focus: MEIF Maven Debt Finance
Boditrax’s technology monitors cellular health and composition to quickly deliver accurate data on up to 45 different metrics, from body fat and muscle to cellular integrity and metabolic efficiency. Boditrax devices are now used by nearly eight million people worldwide to manage their health and fitness journey. The company works with the world’s leading medical, fitness, academic and corporate organisations including the NHS, HM Government, Rolls-Royce, Cadbury’s, Kellogg’s, Virgin Active, David Lloyd, Fitness First, Sky TV, Airbus and many world class hotels, spas and elite sports teams from F1 to the Premier League.
With the UK fitness sector currently valued at £5 billion, Boditrax has plans to capitalise further on this growth by using MEIF funding to accelerate its product development plans and focus on its next generation software and hardware offering, exploring new market sectors and creating a new subscription model. The funding will also support continued R&D and two further product launches.
Established in 2011, Boditrax is backed by an experienced management team led by Executive Chairman Oliver Wheatcroft and Managing Director Nick Stillman. The team have been instrumental in driving Boditrax’s concept, design, implementation, and growth with the company now having the world’s largest body composition database.